Aster DM Sets March 10 Shareholder Vote for Quality Care Merger

A Landmark Merger Nears Final Approval

Aster DM Healthcare Limited is set to take a decisive step towards completing its merger with Quality Care India Limited, a transaction described as the largest in India's hospital sector. The company has scheduled a meeting for its equity shareholders on March 10, 2026, to seek final approval for the scheme of amalgamation. This meeting follows a directive from the National Company Law Tribunal (NCLT), Hyderabad Bench, and marks one of the last major milestones in creating a new healthcare giant. The successful completion of this merger is expected to reshape the competitive landscape of the Indian healthcare industry, establishing a formidable entity with extensive reach and enhanced capabilities.

Key Meeting and Voting Details

To ensure broad participation, the shareholder meeting will be conducted via video conferencing and other audio-visual means. Shareholders will have the opportunity to cast their votes electronically in the days leading up to the meeting. The remote e-voting window is scheduled to open on March 6, 2026, and will close on March 9, 2026. This process provides a convenient and accessible method for shareholders to voice their decision on the proposed amalgamation, which is being pursued under the provisions of the Companies Act, 2013.

The Vision: Creating a Top-Tier Hospital Network

The primary objective of this merger is to create one of the top three hospital chains in India. The combined entity, to be named Aster DM Quality Care Limited, will bring together four prominent healthcare brands: Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare. This consolidation aims to leverage the complementary strengths of each brand, creating a unified network with a shared vision of expanding access to high-quality medical care across the country. The new organization will be jointly promoted by the Aster Promoters and global private equity firm Blackstone, combining deep industry expertise with significant financial backing.

Strategic Scale and Operational Footprint

Upon completion, the merged entity will boast a significant operational scale. As of September 30, 2025, the combined bed strength of Aster DM and Quality Care India stood at over 10,360 beds. The new company plans an aggressive expansion, aspiring to increase its total capacity to approximately 14,715 beds in the coming years. This expanded footprint will span across 9 states and 25 cities, supported by a robust team of over 6,690 clinicians. Such scale is expected to enhance operational efficiencies, improve clinical outcomes, and provide a stronger platform for both brownfield and greenfield expansion projects.

Financial Synergies and Growth Potential

The merger is projected to unlock substantial financial value and operational improvements. Aster DM Healthcare has identified significant synergies with an estimated EBITDA upside potential of 10-15%, calculated based on the pro-forma EBITDA of the merged entity for FY24. The combination is expected to result in stronger financial metrics and improved returns for shareholders. Furthermore, the increased scale will position the company to make strategic investments in advanced medical technologies and digital health platforms, fostering innovation and creating a more integrated patient experience.

Regulatory Milestones Achieved

The path to this final shareholder vote has been cleared by several key regulatory approvals. The merger has already received the green light from the Competition Commission of India (CCI) and obtained 'No Objection' letters from the stock exchanges. Importantly, a preceding share swap arrangement, a critical component of the deal, secured overwhelming support, with 99.998% of shareholders voting in favor. The recent NCLT order directing the company to convene the shareholder and creditor meetings between February 27 and March 13, 2026, was the latest significant regulatory hurdle to be cleared.

Leadership on the Path Forward

Dr. Azad Moopen, Founder and Chairman of Aster DM Healthcare, expressed confidence in the merger's progress. He stated, "We are pleased with the significant progress achieved in the merger process and are confident of shareholders/ unsecured creditors approval. We remain committed to working toward a speedy completion of the merger and look forward to making it effective by Q1 FY2026-27." He emphasized that the focus will be on a disciplined integration strategy that leverages the complementary networks and clinical expertise of both organizations to build a resilient and future-ready healthcare entity.

Market Impact and Industry Consolidation

This transaction highlights a broader trend of consolidation within India's rapidly evolving healthcare sector. The need for greater scale, capital efficiency, and integrated care delivery models is driving companies to combine forces. The creation of Aster DM Quality Care Limited is set to intensify competition and potentially spur further consolidation as other players seek to strengthen their market positions. The merger is a strategic response to the growing demand for high-quality, accessible healthcare services across the country.

Conclusion: Final Steps Towards a Healthcare Giant

With most regulatory hurdles cleared, the upcoming shareholder meeting on March 10 represents the final major step toward the formalization of this landmark merger. Subject to a favorable vote and the completion of remaining formalities, Aster DM Healthcare expects the merger to be completed by the first quarter of the 2026-27 financial year. The successful integration of Aster DM and Quality Care India will establish a powerful new player in the Indian healthcare market, poised for significant growth and innovation.